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Summary A 53-year-old man, who had been treated for penile origin diffuse large
B cell type non-Hodgkin lymphoma (NHL), suffered from right femoral pain and dys-
pnea. Positron emission tomography (PET) revealed abnormal accumulation in his
right femur and cardiac segments. Transthoracic echocardiography revealed massive
localized pericardial effusion with the collapse of both ventricles and the mass-like
echo in the left atrium. We performed emergent pericardiocentesis and diagnosedTransesophageal
echocardiography
this case as a recurrence of NHL with cardiac metastasis. With the use of trans-
esophageal echocardiography (TEE), we conﬁrmed the mass-like echo around the
inter-atrial septum, which directly invaded to the aortic ring and the right atrial wall.
In order to evaluate the effect of chemotherapy, we performed TEE and observed
the precise changes of intra-cardiac tumor size. With the use of TEE monitoring,
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we could select the appropriate chemotherapeutic regimen, and the tumor became
smaller and ﬁnally diminished. The femoral accumulation detected by PET also dis-
appeared. We experienced a case of cardiac metastasis of NHL complicated with left
ventricular diastolic collapse due to the massive localized pericardial effusion. TEE
is a useful tool to evaluate precisely the efﬁcacy of chemotherapy for intra-cardiac
tumors.
e of Cardiology. Published by Elsevier Ireland Ltd. All rights
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Case report
A 53-year-old man felt a tumor on his penis and
visited our hospital in 2005. He was diagnosed as
having diffuse large B cell type non-Hodgkin lym-
phoma (NHL) by the histological analysis of biopsy.
He was treated with chemotherapy R-CHOP reg-
imen (rituximab, cyclophosphamide, doxorubicin,
vincristine, and prednisolone) for four cycles and
radiation therapy, and achieved complete remis-
sion status. Nine months later, in mid-December
2006, he suffered from a painful right femoral
tumor (10-cm diameter) and dyspnea on exertion.
Figure 1 Findings of pericardial effusion from each imagin
showed marked cardiomegaly without lung congestion; (B)
localized pericardial effusion (arrows); (C) and (D) two-dime
pericardial effusion at the posterior side of left ventricle (arr
right ventricle, and the collapse of right ventricle (D: dotted
s
h
l
mositron emission tomography (PET; FDG 226.6MBq)
evealed abnormal accumulations in his right femur
nd cardiac segments. He gradually became dysp-
eic at rest and was admitted to our hospital in late
ecember.
At the time of admission, he was very obese (the
eight was 175 cm and weight 88 kg). The blood
ressure was 124/78mmHg, and the heart rate was
12 beats/min with pulsus paradoxus. The oxygeng modality in admission: (A) the chest roentgenogram
the chest computed tomography showed the massive
nsional echocardiography showed the massive localized
ows), a little pericardial effusion at the anterior side of
arrows).
aturation showed 96% in the room air. Although
e had no cardiac murmur, rales, leg edema, or
ymph node swelling, he showed venous engorge-
ent and the right femoral tumor. His extremities
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cransesophageal echocardiographic observation dur
ere clammy and cold indicating peripheral hypo-
erfusion.
Laboratory data indicated mild liver dysfunction
ue to congestion and low plasma brain natri-
retic protein (BNP) level (51.7 pg/ml). The chest
oentgenogram disclosed an enlarged cardiac sil-
ouette and dull cardio-pleural angles (Fig. 1A).
he electrocardiogram showed sinus tachycardia,
ow voltage in limb leads, incomplete right bundle
ranch block, and right axis deviation. The chest
omputed tomography (CT) demonstrated eccen-
ric distribution of the pericardial effusion (PE),
hich localized to the anterior side of the right
eart and the posterior side of the left ventri-
le (LV) (Fig. 1B). Transthoracic echocardiography
TTE) revealed the massive localized PE in the pos-
erior side of LV and the mass-like echo (dotted
rrow) in the septal side of left atrium (LA) (Fig. 2).
n addition, diastolic compression of the right ven-
ricle (RV) (Fig. 1C and 1D) and LV was observed.
he frame analysis revealed that LV was collapsed in
he early to mid-diastole as shown in Fig. 2. The LV
iameter of end-diastole was slightly small (39mm)
nd the size of the LA reached 51mm. The percent
espiratory change of trans-mitral peak early veloc-
ty was 38% and the diameter of the inferior vena
ava was 28mm with poor respiratory changes.
Judging from the clinical unstable status and
TE ﬁndings, we diagnosed that he was in
linical tamponade enough to need emergent peri-
ardiocentesis. By substernal puncture, massive
i
r
c
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igure 2 Serial echocardiographic images of left ventricular
entricle was collapsed due to the massive posterior pericardia
chocardiography. The feature of left ventricular free wall
owever, the apical side of left ventricle started to dilate,
nward by massive pericardial effusion (arrows). And on the
ould also detect the tumor in the left atrium (dotted arrowschemotherapy for cardiac metastasis 449
emorrhagic ﬂuid (1500ml) was drained from the
ericardial space and his symptoms dramatically
mproved. The ﬂuid contained a lot of malignant
ymphoma cells, which yielded the same histologi-
al ﬁndings as the primary penile lesion. Because
he emergent TTE could not detect the invasion
f the intra-cardiac tumor in detail, we per-
ormed transesophageal echocardiography (TEE)
or the accurate diagnosis of the intra-cardiac
umor. We found that the tumor invaded into
he inter-atrial septum, aortic rings, and right
trial wall and protruded to the atrial cavity
Fig. 3A).
According to these TEE ﬁndings, in order to pre-
ent perforation of the inter-atrial septum and/or
ystemic embolization due to the rapid necrosis of
he tumor, we initially treated him with R-COP reg-
men (rituximab, cyclophosphamide, vincristine,
nd prednisolone), and subsequently addedmethyl-
rednisolone (mPSL) pulse therapy. Although the
olume of ﬂuid from pericardiocentesis gradually
ecreased, the size of intra-cardiac tumor did
ot change on TEE (Fig. 3B), and the femoral
umor became even larger. Therefore, we esca-
ated the intensity of chemotherapy to R-CHOP
egimen for one cycle. Since his cardiac tumor
igniﬁcantly reduced by this regimen without signif-
cant toxicity (Fig. 3C), we selected next R-EPOCH
egimen (rituximab, etoposide, prednisolone, vin-
ristine, cyclophosphamide, and doxorubicin) that
ncluded the similar drugs as R-CHOP regimen but
diastolic collapse. On the early to mid-diastole, the left
l effusion from the apical long-axis view of transthoracic
is normal at end-systole. During early to mid-diastole,
but the posterior side of left ventricle was compressed
end-diastole, the left ventricle enlarged normally. We
).
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Figure 3 Transesophageal echocardiographic ﬁndings during clinical course. On admission, the large tumor at the atrial
septum, aortic ring and posterior wall of the right atrium were detected with transesophageal echocardiography (TEE)
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s(A). We changed the regimen, R-COP (B), R-CHOP (C), R-
we evaluated the tumor size and the features with TEE m
of the tumor.
could reduce the cumulative toxicity of doxoru-
bicin through continuous infusion of the drug [1].
Although two cycles of R-EPOCH reduced the size
of cardiac tumor markedly, TEE revealed that there
remained tumors in the inter-atrial septum and
right atrium (RA) (Fig. 3D). Next we chose R-CHASE
regimen (rituximab, cyclophosphamide, etoposide,
cytarabine, and dexamethasone), which is the new
salvage chemotherapy for patients with refrac-
tory or relapsed lymphoma. After four cycles of
this regimen, we conﬁrmed the disappearance of
the cardiac tumor by TEE (Fig. 3E) as well as
the lesions in the right femur and the heart by
PET. Thus, a diagnosis of complete remission was
made. Finally, we treated him with myeloabla-
tive high-dose chemotherapy by the use of the
modiﬁed R-BEAM regimen (rituximab, ranimustine,
etoposide, cytarabine, and melphalan), which was
followed by autologous peripheral blood stem cell
transplantation (PBSCT) rescue. He was discharged
from our hospital in a stable condition in October
2007.
L
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oCH (D), and R-CHASE (E), and after each chemotherapy,
toring (arrows) and ﬁnally conﬁrmed the disappearance
iscussion
t is reported that cardiac tamponade due to malig-
ant disease is usually fatal [2]. A widely accepted
chocardiographic sign of cardiac tamponade is the
ollapse of RA and RV associated with circumferen-
ial effusions [2], and the reports of left ventricular
iastolic collapse (LVDC) are rare [3]. In this case,
TE showed the collapse of both ventricles. The
echanism of RV collapse is explained as that the
arly diastolic LV expansion compresses the ﬂuid
o right-side pericardial spaces, then increases RV
ericardial pressure exceeds diastolic RV pressure
nd ﬁnally presses RV free wall [4]. Similar to RV
iastolic collapse, LV diastolic collapse is caused
y increased LV pericardial pressure via LV expan-
ion in the limited space. It was reported that
VDC was sometimes observed in the case of the
ost-operation [5] or malignant tumors [6]. In such
ases, it was reported that non-circumferential and
ocalized PE was detected due to adhesion after
peration or invasion of the tumor. This ﬁnding is
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Rransesophageal echocardiographic observation dur
hought to be the difference of right- and left-side
ericardial chamber compliance indicating partial
dhesion of the heart and pericardium.
In our case, PE mainly located in the pos-
erior side of LV as shown in Fig. 1B—D non-
ircumferentially. We thought that the tumor
nvaded and adhered to the cardiac wall and peri-
ardial cavity, and then caused the localized PE.
e, however, could not show the deﬁnite ﬁndings
hat indicate the adhesion or invasion on imag-
ng modalities. After the pericardiocentesis, the
atient’s symptoms were dramatically improved
nd LVDC was not detected. Therefore we thought
hat the localized PE due to adhesion and invasion
f the tumor was mainly involved in the appearance
f cardiac tamponade.
The diagnostic echocardiographic features of
VDC have been reported as follows. D’cruz et al.
oted an abnormal diastolic contour of the left ven-
ricular posterior wall such as paradoxical motion
n M-mode echocardiography [7]. A similar ﬁnd-
ng was observed in M-mode echocardiography of
n operative patient reported by Jones et al. on
he late isolated left ventricular tamponade [8].
su et al. reported that a case of LVDC caused by
alignant PE showed the abnormal contour of the
eft ventricular posterior wall motion similar to our
ase by frame analysis of two-dimensional echocar-
iography [6]. These reports indicated that LVDC
eant the existence of hemodynamically consider-
ble cardiac tamponade.
Although we could not evaluate M-mode
chocardiography because of the patient’s orthop-
ea on admission, we detected obvious LVDC of
he posterior wall in the early to mid-diastole,
y the use of two-dimensional echocardiography
s shown in Fig. 2. Judging from LVDC and his
evere symptoms, we diagnosed him in severe
ardiac tamponade, and subsequently performed
he emergent pericardiocentesis via the substernal
pproach. After the drainage from the anterior
paces of right heart, his symptoms were dramat-
cally improved and both right- and left-side PE
ere decreased. It means that there were some
ommunications between right- and left-side PE.
It has been reported that the frequency of pri-
ary cardiac tumor is only 20% of total cardiac
umors and the rest were metastatic cases [9].
egarding the cases of malignant lymphoma, car-
iac metastasis was reported to occur in 24% [10].
ut the cardiac metastasis is often recognized for
he ﬁrst time in autopsy because of the difﬁculty to
iagnose. Previous reports indicated that the recent
dvances in chemotherapy improved the progno-
is of malignant lymphoma, when the appropriate
herapeutic regimen was selected by the accuratechemotherapy for cardiac metastasis 451
valuation of therapeutic effects. Regarding the
hemotherapy, rituximab has been reported as an
ffective drug for cardiac lymphoma [11].
Our patient was followed up with PET after his
rst chemotherapy for the penile lesion of NHL, and
e noticed the recurrence of NHL in the femur and
he heart with PET. The ﬁnding with PET, however,
nly suggested the possibility of tumor existence
n the cardiac segment. Regarding PET, we could
udge the existence of cardiac tumor, but could not
etect the extent of the size or the feature of tumor
dequately. Furthermore, PET is too expensive for
requent monitoring of chemotherapeutic effects.
s to CT, CT does not scan continuously and has a
imitation in the slicing width. CT, therefore, could
ot have estimated the cardiac tumor in detail. If
e had performed CT with a contrast medium, it
ight have caused renal failure in association with
he side effects of chemotherapy. The most impor-
ant problem in PET and CT scan is the exposition
o radiation for the frequent repeat monitoring of
he chemotherapeutic effect in a short period.
Thus, we selected echocardiography for mon-
toring the effect of chemotherapy. Because of
arked obesity (BMI 28.7), although we could
etect the existence of tumor in LA with TTE, we
ould not elucidate the feature, precise size, or
nﬁltration of the intra-cardiac tumor. With TEE
onitoring, on the other hand, we could ﬁnd that
he tumor invaded to the inter-atrial septum and
he atrial cavity in detail, which was thought to
e a risk factor for the perforation of the inter-
trial septum and systemic embolization. Although
EE might be a semi-invasive tool, we considered
hat the information of TEE performed by the well-
rained operator exceeds the obscure images of
TE in this case. Therefore, we decided to use
EE for monitoring the cardiac tumor, and carefully
hanged the chemotherapy protocols according
o TEE ﬁndings. As mentioned earlier, we could
hoose the appropriate ﬁve regimens, and the
atient ﬁnally achieved complete remission of the
isease.
In summary, this report highlights the usefulness
f TEE for the evaluation of intra-cardiac tumor and
he efﬁcacy of chemotherapy. We also highlighted
VDC which was due to massive localized PE by car-
iac metastasis of NHL.
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